March 2023

Copycat GLP-1s and more perspectives across metabolic and obesity care – 326

Copycat GLP-1s and more: perspectives across metabolic and obesity care – 3/26

AT A GLANCE… Copycat, compounded drugs for weight loss – multiple stories here, here and here. Altimmune presents an interim analysis this week on 160 subjects in the MOMENTUM Phase 2 Obesity Trial. Higher plasma caffeine concentrations were associated with lower body mass index and fat mass, as well as a lower risk of type 2 diabetes. EVENTS Not a ton of excitement […]

Copycat GLP-1s and more: perspectives across metabolic and obesity care – 3/26 Read More »

Best actor Oscar for portrayal of reclusive 600lb male, and more perspectives across metabolic and obesity care – 319

Best actor Oscar for portrayal of reclusive 600lb male, and more: perspectives across metabolic and obesity care – 3/19

AT A GLANCE… The Oscar ceremony mocks Ozempic takers in Hollywood; Brendan Fraser wins best actor for his portrayal of a 600-lb gay man in The Whale. The Guardian, a British daily newspaper, reports on Novo Nordisk and its ‘orchestrated PR campaign’ to achieve regulatory approval Researchers calculate Medicare Part D would be on the hook for $27B, or 20% of its total budget,

Best actor Oscar for portrayal of reclusive 600lb male, and more: perspectives across metabolic and obesity care – 3/19 Read More »

Global metabolic trouble, cardio risks increasing for young adults, and the rest of the metabolic and obesity care roundup - 312

Global metabolic trouble, cardio risks increasing for young adults, and the rest of the metabolic and obesity care roundup – 3/12

AT A GLANCE… WeightWatchers enters definitive agreement to acquire Sequence, a telehealth weight management program, with a focus upon GLP-1 medications; closely followed by Noom Clinical, a new offering to meet demand for weight loss medications. The UK National Health Service approved Novo Nordisk drug Wegovy for weight loss, though at higher BMI entry criteria of 35, and for a maximum

Global metabolic trouble, cardio risks increasing for young adults, and the rest of the metabolic and obesity care roundup – 3/12 Read More »

Global obesity, its (massive) costs, and the rest of the metabolic and obesity care roundup

Global obesity, its (massive) costs, and the rest of the metabolic and obesity care roundup – 3/5

Dear Friends, a ton of activity on metabolic and obesity care, with Obesity Care Week, publication of report from the World Obesity Forum, all in advance of World Obesity Day on March 4. AT A GLANCE… Publication of the World Obesity Atlas estimates a $4.32 trillion cost to the global economy, or 3% of global GDP by 2035,

Global obesity, its (massive) costs, and the rest of the metabolic and obesity care roundup – 3/5 Read More »

Scroll to Top
Skip to content